[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Autism Spectrum Disorders Treatment Market Size Study & forecast, by Drug Class (Antipsychotic Drugs, SSRIs/Antidepressants, Stimulants, Other Drug Classes) by Type (Autistic Disorder, Asperger's Syndrome, Other Types), by Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029

May 2023 | 200 pages | ID: GA1D45BAD55AEN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Autism Spectrum Disorders Treatment Market is valued at approximately USD 1.85 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that affects social interaction, communication, and behavior. It is called a spectrum disorder because the symptoms and severity can vary widely among individuals. ASD is typically diagnosed in early childhood, but sometimes it is not identified until later in life. Some common symptoms of ASD include difficulties with social interactions and communication, repetitive behaviors, and a strong focus on specific interests or topics. The key factor supporting the market growth is the rising burden of autism spectrum disorder (ASD) globally, growing awareness pertaining to ASD and rising number of investments, and the growing number of government initiatives such as forming various foundations and sanctioning different funding for the awareness of autism in various countries is anticipated to create the lucrative demand for the market during the forecast period.

However, Autism Spectrum Disorders Treatment Market Growth is driven by the rising prevalence of autism spectrum disorder (ASD) and the rising diagnostic rate of ASD. For instance, the World Health Organization (WHO) estimates that in March 2022, one in 100 children globally will have autism spectrum disorder. Early detection of ASD is essential to comprehending and managing the condition. According to numerous research, the average age of diagnosis is between 3 and 6 years old, with considerable variations depending on the socioeconomic level and ethnic origin. Additionally, rising R&D activity for advancements in autism spectrum disorder treatment, and new product development and product approvals are anticipated to create a lucrative opportunity for the market during the forecast period. However, the high cost of autism spectrum disorder treatment and diagnosis and stringent regulations pertaining to product approval stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Autism Spectrum Disorders Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, the growing prevalence of autism disorder across the U.S., coupled with the growing adoption and uptake of therapies. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as rising demand for effective treatment. The development of healthcare infrastructure to fulfil the need for well-equipped healthcare institutions such as hospitals would create lucrative growth prospects for the Autism Spectrum Disorders Treatment market across the Asia Pacific region.

Major market player included in this report are:
Curemark, LLC (Rye, U.S.)
Alembic Pharmaceuticals Limited (Vadodara, India)
Yamo Pharmaceuticals (New York, U.S.)
PaxMedica, Inc. (Woodcliff Lake, U.S.)
F. Hoffmann-La Roche Ltd (Basel, Switzerland)
Aurobindo Pharma Ltd. (Hyderabad, India)
Otsuka Holdings Co. Ltd. (Tokyo, Japan)
Janssen Pharmaceuticals, Inc. (Titusville, New Jersey)
Teva Pharmaceutical Industries Ltd. (Tel Aviv, Israel)
H. Lundbeck A/S (Copenhagen, Denmark)

Recent Developments in the Market:
In Oct. 2021, Axial Therapeutics reported that the FDA approved the company's Investigational New Drug (IND) application for its lead product, AB-2004, a molecular therapy that is being investigated for the treatment of irritability associated with ASD.
Global Autism Spectrum Disorders Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
Antipsychotic Drugs
SSRIs/Antidepressants
Stimulants
Other Drug Classes
By Type:
Autistic Disorder
Asperger's Syndrome
Other Types
By Distribution Channel:
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  1.2.1. Autism Spectrum Disorders Treatment Market, by Region, 2019-2029 (USD Billion)
  1.2.2. Autism Spectrum Disorders Treatment Market, by Drug Class, 2019-2029 (USD Billion)
  1.2.3. Autism Spectrum Disorders Treatment Market, by Type, 2019-2029 (USD Billion)
  1.2.4. Autism Spectrum Disorders Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL AUTISM SPECTRUM DISORDERS TREATMENT MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL AUTISM SPECTRUM DISORDERS TREATMENT MARKET DYNAMICS

3.1. Autism Spectrum Disorders Treatment Market Impact Analysis (2019-2029)
  3.1.1. Market Drivers
    3.1.1.1. Rising burden of autism spectrum disorder (ASD) globally
    3.1.1.2. Growing awareness pertaining to ASD and rising number of investments
  3.1.2. Market Challenges
    3.1.2.1. High cost of autism spectrum disorder treatment and diagnosis
    3.1.2.2. Stringent regulations pertaining to product approval
  3.1.3. Market Opportunities
    3.1.3.1. Rising R&D activity for advancements in autism spectrum disorder treatment

CHAPTER 4. GLOBAL AUTISM SPECTRUM DISORDERS TREATMENT MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
  4.3.1. Political
  4.3.2. Economical
  4.3.3. Social
  4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

CHAPTER 6. GLOBAL AUTISM SPECTRUM DISORDERS TREATMENT MARKET, BY DRUG CLASS

6.1. Market Snapshot
6.2. Global Autism Spectrum Disorders Treatment Market by Drug Class, Performance - Potential Analysis
6.3. Global Autism Spectrum Disorders Treatment Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Autism Spectrum Disorders Treatment Market, Sub Segment Analysis
  6.4.1. Antipsychotic Drugs
  6.4.2. SSRIs/Antidepressants
  6.4.3. Stimulants
  6.4.4. Other Drug Classes

CHAPTER 7. GLOBAL AUTISM SPECTRUM DISORDERS TREATMENT MARKET, BY TYPE

7.1. Market Snapshot
7.2. Global Autism Spectrum Disorders Treatment Market by Type, Performance - Potential Analysis
7.3. Global Autism Spectrum Disorders Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
7.4. Autism Spectrum Disorders Treatment Market, Sub Segment Analysis
  7.4.1. Autistic Disorder
  7.4.2. Asperger's Syndrome
  7.4.3. Other Types

CHAPTER 8. GLOBAL AUTISM SPECTRUM DISORDERS TREATMENT MARKET, BY DISTRIBUTION CHANNEL

8.1. Market Snapshot
8.2. Global Autism Spectrum Disorders Treatment Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Autism Spectrum Disorders Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Autism Spectrum Disorders Treatment Market, Sub Segment Analysis
  8.4.1. Hospital Pharmacies
  8.4.2. Drug Stores and Retail Pharmacies
  8.4.3. Online Pharmacies

CHAPTER 9. GLOBAL AUTISM SPECTRUM DISORDERS TREATMENT MARKET, REGIONAL ANALYSIS

9.1. Autism Spectrum Disorders Treatment Market, Regional Market Snapshot
9.2. North America Autism Spectrum Disorders Treatment Market
  9.2.1. U.S. Autism Spectrum Disorders Treatment Market
    9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    9.2.1.2. Type breakdown estimates & forecasts, 2019-2029
    9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
  9.2.2. Canada Autism Spectrum Disorders Treatment Market
9.3. Europe Autism Spectrum Disorders Treatment Market Snapshot
  9.3.1. U.K. Autism Spectrum Disorders Treatment Market
  9.3.2. Germany Autism Spectrum Disorders Treatment Market
  9.3.3. France Autism Spectrum Disorders Treatment Market
  9.3.4. Spain Autism Spectrum Disorders Treatment Market
  9.3.5. Italy Autism Spectrum Disorders Treatment Market
  9.3.6. Rest of Europe Autism Spectrum Disorders Treatment Market
9.4. Asia-Pacific Autism Spectrum Disorders Treatment Market Snapshot
  9.4.1. China Autism Spectrum Disorders Treatment Market
  9.4.2. India Autism Spectrum Disorders Treatment Market
  9.4.3. Japan Autism Spectrum Disorders Treatment Market
  9.4.4. Australia Autism Spectrum Disorders Treatment Market
  9.4.5. South Korea Autism Spectrum Disorders Treatment Market
  9.4.6. Rest of Asia Pacific Autism Spectrum Disorders Treatment Market
9.5. Latin America Autism Spectrum Disorders Treatment Market Snapshot
  9.5.1. Brazil Autism Spectrum Disorders Treatment Market
  9.5.2. Mexico Autism Spectrum Disorders Treatment Market
  9.5.3. Rest of Latin America Autism Spectrum Disorders Treatment Market
9.6. Rest of The World Autism Spectrum Disorders Treatment Market

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Top Market Strategies
10.2. Company Profiles
  10.2.1. Curemark, LLC (Rye, U.S.)
    10.2.1.1. Key Information
    10.2.1.2. Overview
    10.2.1.3. Financial (Subject to Data Availability)
    10.2.1.4. Product Summary
    10.2.1.5. Recent Developments
  10.2.2. Alembic Pharmaceuticals Limited (Vadodara, India)
  10.2.3. Yamo Pharmaceuticals (New York, U.S.)
  10.2.4. PaxMedica, Inc. (Woodcliff Lake, U.S.)
  10.2.5. F. Hoffmann-La Roche Ltd (Basel, Switzerland)
  10.2.6. Aurobindo Pharma Ltd. (Hyderabad, India)
  10.2.7. Otsuka Holdings Co. Ltd. (Tokyo, Japan)
  10.2.8. Janssen Pharmaceuticals, Inc. (Titusville, New Jersey)
  10.2.9. Teva Pharmaceutical Industries Ltd. (Tel Aviv, Israel)
  10.2.10. H. Lundbeck A/S (Copenhagen, Denmark)

CHAPTER 11. RESEARCH PROCESS

11.1. Research Process
  11.1.1. Data Mining
  11.1.2. Analysis
  11.1.3. Market Estimation
  11.1.4. Validation
  11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES

TABLE 1. Global Autism Spectrum Disorders Treatment Market, report scope
TABLE 2. Global Autism Spectrum Disorders Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Autism Spectrum Disorders Treatment Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Autism Spectrum Disorders Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 5. Global Autism Spectrum Disorders Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 6. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Autism Spectrum Disorders Treatment Market
TABLE 71. List of primary sources, used in the study of global Autism Spectrum Disorders Treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Autism Spectrum Disorders Treatment Market, research methodology
FIG 2. Global Autism Spectrum Disorders Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Autism Spectrum Disorders Treatment Market, key trends 2021
FIG 5. Global Autism Spectrum Disorders Treatment Market, growth prospects 2022-2029
FIG 6. Global Autism Spectrum Disorders Treatment Market, porters 5 force model
FIG 7. Global Autism Spectrum Disorders Treatment Market, pest analysis
FIG 8. Global Autism Spectrum Disorders Treatment Market, value chain analysis
FIG 9. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Autism Spectrum Disorders Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America Autism Spectrum Disorders Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Autism Spectrum Disorders Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Autism Spectrum Disorders Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Autism Spectrum Disorders Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Autism Spectrum Disorders Treatment Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable


More Publications